PRINCETON, December 13, 2023: Morgan Lewis advised Integra LifeSciences Holdings Corporation in a definitive agreement to acquire Acclarent from Ethicon, a Johnson & Johnson company, for $275 million in cash at closing.
Integra LifeSciences is a global medical technology company delivering treatment pathways to advance patient outcomes and set new standards of surgical, neurologic, and regenerative care. Acclarent is a medical device company supporting ear, nose, and throat (ENT) surgeons delivering minimally invasive technologies.
Morgan Lewis partners Benjamin Wills and Conor Larkin and associates Erin O’Gurek and Matthew Sherman are representing Integra LifeSciences.